CTOs on the Move

DNA2.0

www.dna20.com

 
DNA2.0 is a privately-held, leading synthetic genomics company, headquartered in Menlo Park, CA.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.dna20.com
  • 1430 Obrien Dr Ste E
    Menlo Park, CA USA 94025
  • Phone: 650.853.8347

Executives

Name Title Contact Details

Similar Companies

Midwest Health Care

Midwest Health Care is a Cape Girardeau, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

National Kidney Registry

The National Kidney Registry is a national registry in the United States listing kidney donors and recipients in need of a kidney transplant.

Difference Card

The Difference Card helps organizations build the most cost effective health plan. Since 2001, The Difference Card has provided its clients with an average net savings of over 18%. The product utilizes proprietary medical reimbursement systems, risk transfer solutions and wellness strategies. In doing so, The Difference Card has delivered millions of dollars in savings to its clients while at the same time providing the highest level of employee benefits. With 13 offices across the United States, The Difference Card provides a national presence combined with local expertise and service. Through strategic broker partnerships, The Difference Card delivers custom plan design solutions that exceeds the needs of both employers and employees across the country.

Trellus Health

Trellus Health is the leader in resilience-driven care for complex chronic conditions. Our multidisciplinary connected health solution coordinates expert-driven personalized care, including clinical and behavioral health, to improve outcomes and reduce costs for patients, employers, and the entire healthcare system.

Aprecia

Aprecia, The 3DP Pharmaceutical Company, expects to use its ZipDose® Technology to transform the way people take medicine. Its first innovation, ZipDose Technology can be combined with a wide variety of active pharmaceutical ingredients to create rapidly disintegrating oral dosage forms that are easy to take and easy to administer. Aprecia is committed to enhancing the patient experience through novel approaches to drug delivery that address unmet treatment needs to eliminate patient suffering and caregiver burden.